Clinical trial
Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis
Primary Outcome Measures:
To measure the relationship of calcium and PTH levels to PSA levels in patients receiving a prostate biopsy. [ Time Frame: Day 1 ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Serum samples for measurement of PTHrP
Estimated Enrollment: 500
Study Start Date: May 2013
Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)
| Category | Value |
|---|---|
| Study start date | 2013-05-01 |